Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments

Sandomenico, Annamaria, Sivaccumar, Jwala P., Ruvo, Menotti·2020·International Journal of Molecular Sciences
DOI 10.3390/ijms21176324

Cites (247)

Items 201–246 of 246

  1. Rapid Generation of Monoclonal Antibodies from Single B Cells by Ecobody Technology
    Ojima-Kato, Teruyo, Morishita, Shiomi, Uchida, Yoshino, Nagai, Satomi, Kojima, Takaaki, Nakano, Hideo · 2018 · Antibodies
  2. Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2
    Nicolle H. Rekers, Catharina M.L. Zegers, Wilfred T.V. Germeraad · 2015 · OncoImmunology
  3. Carboxy-Terminal Region Involved in Activity of Escherichia coli TolC
    Hiroyasu Yamanaka, Hiroshi Izawa, Keinosuke Okamoto · 2001 · Journal of Bacteriology
  4. <i>Escherichia coli</i> “TatExpress” strains export several g/L human growth hormone to the periplasm by the Tat pathway
    Guerrero Montero, Isabel, Richards, Kirsty L., Jawara, Chillel, Browning, Douglas F., Peswani, Amber R., Labrit, Mickael, Allen, Matthew, Aubry, Cedric, Davé, Emma, Humphreys, David P. et al. · 2019 · Biotechnology and Bioengineering
  5. Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α
    Eyad Elkord, Deborah J. Burt, Anette Sundstedt · 2015 · Oncotarget
  6. Recombinant production of a VL single domain antibody in Escherichia coli and analysis of its interaction with peptostreptococcal protein L
    Cossins, Aimee J., Harrison, Steven, Popplewell, Andrew G., Gore, Michael G. · 2007 · Protein Expression and Purification
  7. Formation of dimeric Fabs in Escherichia coli: effect of hinge size and isotype, presence of interchain disulphide bond, Fab′ expression levels, tail piece sequences and growth conditions
    David P. Humphreys, Andrew P. Chapman, Dominic G. Reeks · 1997 · Journal of Immunological Methods
  8. Coupling between codon usage, translation and protein export in <i>Escherichia coli</i>
    Zalucki, Yaramah M., Beacham, Ifor R., Jennings, Michael P. · 2011 · Biotechnology Journal
  9. A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coli
    Petrus, Marloes L. C., Kiefer, Lukas A., Puri, Pranav, Heemskerk, Evert, Seaman, Michael S., Barouch, Dan H., Arias, Sagrario, van Wezel, Gilles P., Havenga, Menzo · 2019 · Applied Microbiology and Biotechnology
  10. Construction of multiform scFv antibodies using linker peptide
    Wang, Shihua, Zheng, Cengjie, Liu, Ying, Zheng, Huirong, Wang, Zonghua · 2008 · Journal of Genetics and Genomics
  11. Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E. coli
    Kulmala, Antti, Huovinen, Tuomas, Lamminmäki, Urpo · 2017 · Scientific Reports
  12. Effect of molecular chaperone on the soluble expression of recombinant fab fragment in E. coli
    Farajnia, Safar, Ghorbanzadeh, Vajihe, Dariushnejad, Hassan · 2020 · International Journal of Peptide Research and Therapeutics
  13. Effect of DnaK/DnaJ/GrpE and DsbC Chaperons on Periplasmic Expression of Fab Antibody by E. coli SEC Pathway
    Dariushnejad, Hassan, Farajnia, Safar, Zarghami, Nosratollah, Aria, Maryam, Tanomand, Asghar · 2019 · International Journal of Peptide Research and Therapeutics
  14. Miniaturised ‘antibody’-drug conjugates for solid tumours?
    Mahendra P. Deonarain · 2018 · Drug Discovery Today Technologies
  15. Construction and periplasmic expression of the Anti-EGFRvIII ScFv antibody gene in Escherichia coli
    DEWI, Kartika Sari · 2016 · Scientia Pharmaceutica
  16. Ultra-performance liquid chromatography/multiple reaction monitoring mass spectrometry quantification of trastuzumab in human serum by selective monitoring of a specific peptide marker from the antibody complementarity-determining regions
    Russo, R., Rega, C., Caporale, A., Tonon, G., Scaramuzza, S., Selis, F., Ruvo, M., Chambery, A. · 2017 · Rapid Communications in Mass Spectrometry
  17. A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in <i>Escherichia coli</i>
    Xu, Li, Song, Xiaoyu, Jia, Lingyun · 2017 · Biotechnology and Applied Biochemistry
  18. Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source
    Kim, Se Jun, Ha, Gyong Sik, Lee, Gyunghwa, Lim, Sung In, Lee, Chung Min, Yang, Yoo Hee, Lee, JaeMin, Kim, Ju Eun, Lee, Jae Hee, Shin, YongUk et al. · 2018 · Enzyme and Microbial Technology
  19. Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
    Luke Anthony Coyle, Nicholas J. Morley, Alessandro Rambaldi · 2018 · Blood
  20. Safety and efficacy of VAL-1221, a novel fusion protein targeting cytoplasmic glycogen, in patients with late-onset Pompe disease
    Priya Sunil Kishnani, Robin Lachmann, Tahseen Mozaffar · 2019 · Molecular Genetics and Metabolism
  21. A promising cancer diagnosis and treatment strategy: Targeted cancer therapy and imaging based on antibody fragment
    Zhao, Xuhong, Ning, Qian, Mo, Zhongcheng, Tang, Shengsong · 2019 · Artificial Cells, Nanomedicine, and Biotechnology
  22. Safety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours
    Funda Meric‐Bernstam, D. Hanna, M. Beeram et al. · 2019 · Annals of Oncology
  23. Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli
    Kamal Veisi, Safar Farajnia, Nosratollah Zarghami, Hamid Reza Khoram Khorshid, Nasser Samadi, Shiva Ahdi Khosroshahi, Hossein Zarei Jaliani · 2015 · Advanced Pharmaceutical Bulletin
  24. Cytosolic expression of functional Fab fragments in <i>Escherichia coli</i> using a novel combination of dual SUMO expression cassette and EnBase<sup>®</sup> cultivation mode
    Rezaie, F., Davami, F., Mansouri, K., Agha Amiri, S., Fazel, R., Mahdian, R., Davoudi, N., Enayati, S., Azizi, M., Khalaj, V. · 2017 · Journal of Applied Microbiology
  25. Preparation of single-chain Fv antibodies in the cytoplasm of Escherichia coli by simplified and systematic chaperone optimization
    Liu, Chenjiang, Kobashigawa, Yoshihiro, Yamauchi, Soichiro, Toyota, Yuya, Teramoto, Manaka, Ikeguchi, Yuka, Fukuda, Natsuki, Sato, Takashi, Sato, Yuko, Kimura, Hiroshi et al. · 2019 · The Journal of Biochemistry
  26. Improvement of Fab expression by screening combinatorial synonymous signal sequence libraries
    Antti Kulmala, Tuomas Huovinen, Urpo Lamminmäki · 2019 · Microbial Cell Factories
  27. Monoclonal Antibodies: A Prospective and Retrospective View
    Sivaccumar, Jwala, Sandomenico, Annamaria, Vitagliano, Luigi, Ruvo, Menotti · 2021 · Current Medicinal Chemistry
  28. In situ magnetic separation of antibody fragments from Escherichia coli in complex media
    Martin Cerff, Alexander Scholz, Matthias Franzreb · 2013 · BMC Biotechnology
  29. Phase 1 dose escalation of ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-expressing cancers.
    Funda Meric‐Bernstam, Muralidhar Beeram, Mariela Anabel Blum et al. · 2017 · Journal of Clinical Oncology
  30. Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion
    Natsuki Fukuda, Kentaro Noi, Lidong Weng et al. · 2017 · Molecules
  31. SKIK-zipbody-alkaline phosphatase, a novel antibody fusion protein expressed in Escherichia coli cytoplasm
    Ritthisan, Panwad, Ojima-Kato, Teruyo, Damnjanović, Jasmina, Kojima, Takaaki, Nakano, Hideo · 2018 · Journal of Bioscience and Bioengineering
  32. Co-expression of Dsb proteins enables soluble expression of a single-chain variable fragment (scFv) against human type 1 insulin-like growth factor receptor (IGF-1R) in E. coli
    Sun, Xue-Wen, Wang, Xiao-Hua, Yao, Yan-Bing · 2014 · World Journal of Microbiology and Biotechnology
  33. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli
    Noguchi, Tomoaki, Nishida, Yuichi, Takizawa, Keiji, Cui, Yue, Tsutsumi, Koki, Hamada, Takashi, Nishi, Yoshisuke · 2017 · Journal of Immunological Methods
  34. Untitled work
    2018 · Europe PMC (PubMed Central)
  35. Tc-99m Nofetumomab Merpentan Complements an Equivocal Bone Scan for Detecting Skeletal Metastatic Disease From Lung Cancer
    MICHELLE R. STRAKA, JUDITH M. JOYCE, Daniel T. Myers · 2000 · Clinical Nuclear Medicine
  36. In vitro generation of anti-hepatitis B monoclonal antibodies from a single plasma cell using single-cell RT-PCR and cell-free protein synthesis
    Sabrina, Yunita, Ali, Muhamad, Nakano, Hideo · 2010 · Journal of Bioscience and Bioengineering
  37. Extracellular production of functional single-chain variable fragment against aflatoxin B<sub>1</sub>using<i>Escherichia coli</i>
    Na, K.-I., Kim, S.-J., Choi, D.-S., Min, W.-K., Kim, S.-G., Seo, J.-H. · 2019 · Letters in Applied Microbiology
  38. Engineering a single-chain antibody against Trypanosoma cruzi metacyclic trypomastigotes to block cell invasion
    Demeu, Lara Maria Kalempa, Soares, Rodrigo Jahn, Miranda, Juliana Severo, Pacheco-Lugo, Lisandro A., Oliveira, Kelin Gonçalves, Cortez Plaza, Cristian Andrés, Billiald, Philippe, Ferreira de Moura, Juliana, Yoshida, Nobuko, Alvarenga, Larissa Magalhães et al. · 2019 · PLOS ONE
  39. Development of a dual monoclonal antibody sandwich enzyme-linked immunosorbent assay for the detection of swine influenza virus using rabbit monoclonal antibody by Ecobody technology
    Sila-on, Daorung, Chertchinnapa, Phornnaphat, Shinkai, Yusuke, Kojima, Takaaki, Nakano, Hideo · 2020 · Journal of Bioscience and Bioengineering
  40. Convenient method of producing cyclic single-chain Fv antibodies by split-intein-mediated protein ligation and chaperone co-expression
    Liu, Chenjiang, Kobashigawa, Yoshihiro, Yamauchi, Soichiro, Fukuda, Natsuki, Sato, Takashi, Masuda, Takeshi, Ohtsuki, Sumio, Morioka, Hiroshi · 2020 · The Journal of Biochemistry
  41. Isolation of induced pluripotent cells from stromal liver cells of patients with alcoholic cirrhosis
    Kholodenko, I. V., Kholodenko, R. V., Manukyan, G. V., Lupatov, A. Yu., Yarygin, K. N. · 2017 · Bulletin of Experimental Biology and Medicine
  42. A phase II study of intratumoral application of L19IL2/L19TNF in melanoma patients in clinical stage III or stage IV M1a with presence of injectable cutaneous and/or subcutaneous lesions.
    Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo et al. · 2014 · Journal of Clinical Oncology
  43. Abstract B001: Safety and efficacy of ZW25, a HER2-targeted bispecific antibody, in combination with chemotherapy in patients with locally advanced and/or metastatic HER2-expressing gastroesophageal cancer
    Funda Meric‐Bernstam, Jorge M Chaves, Do‐Youn Oh et al. · 2019 · Molecular Cancer Therapeutics
  44. Proteomics investigation of molecular mechanisms affected by EnBase culture system in anti-VEGF fab fragment producingE.coliBL21 (DE3)
    Bahareh Azarian, Amin Azimi, Mahboubeh Sepehri, Vahideh Samimi Fam, Faegheh Rezaie, Yeganeh Talebkhan, Vahid Khalaj, Fatemeh Davami · 2019 · Preparative Biochemistry & Biotechnology
  45. Vobarilizumab. Anti-interleukin-6 receptor subunit alpha (CD126; IL-6R), Treatment of rheumatoid arthritis, Treatment of systemic lupus erythematosus
    Kate Haddley · 2018 · Drugs of the Future
  46. Anifrolumab. Anti-interferon-alpha receptor 1 (IFNAR1) monoclonal antibody, Treatment of systemic lupus erythematosus
    K. Haddley · 2018 · Drugs of the Future